Home Contact Us 中文 English
Yourlocation:Home >News> Treatment of Irritable Bowel Syndrome with Trimebutine Maleate and Bifidobacterium

Treatment of Irritable Bowel Syndrome with Trimebutine Maleate and Bifidobacterium

Time:2017/7/13 17:14:09

To investigate the clinical efficacy of trimebutine maleate combined with bifidobacteria triple therapy in the treatment of irritable bowel syndrome.

Methods: 88 patients with irritable bowel syndrome were randomly divided into observation group and control group according to the random number method. After treatment for 4 weeks, the symptoms were alleviated.

Results: The total effective rate was 93.18% in the observation group, which was significantly higher than that in the control group (84.09%), the difference was statistically significant (P <0.05). Only one of the two groups had dry mouth and disappeared after taking the drug.

Conclusion: Trimebutine maleate combined with Bifidobacterium triple live stromal capsules has a good curative effect on the treatment of irritable bowel syndrome and its clinical application is high.